Zeta Corporation

Zeta Corporation would like to focus on the proliferation markers in this post. We would like to present some facts about CD79a from the desk of our pathologist. Zeta designs and develops tumor-specific biomarkers using cutting-edge technology to uniquely select the immunogens for our famed RAbMono (Rabbit Monoclonal) and MonoMab (Monospecific monoclonal antibodies). Zeta’s MonoMab Antibodies are produced through hybridoma and recombinant technologies. # #IVD #antibodies #Pathology #IHC

Playing a key role in the development of the brain and nervous system, anaplastic lymphoma kinase (ALK) protein is typically present at low levels in healthy individuals. The genes fused with the ALK gene in various chromosomal translocations in different types of hematological malignancies and solid tumors. The ALK gene fusion products result in overexpression and ALK chimeric proteins, which can be detected by ALK-specific antibody immunohistochemistry. Zeta is launching a RAbMono (Rabbit Monoclonal) ALK-1, clone ZR305. Utilize the ZR305 RAbMono clone for both the ALCL and NSCLC. #IVD #Antibodies #Pathology #IHC

All of us at Zeta would like to wish you a Happy Lunar New Year and a prosperous & healthy 2021! #HappyNewYear #lunarnewyear

Zeta offers RAbMonoTM (Rabbit Monoclonals) antibodies for the breast markers and they are uniquely designed and developed at Zeta. These have been tested and validated by leading laboratories globally and external quality control institutions like the NordicQC. *Click on the images below to learn more: #IVD #pathology #antibodies #diagnostics #IHC

MonoMAb from Zeta Corporation! Zeta is expanding the portfolio of our Unique MonoSpecific monoclonal antibodies. #IVD #Antibodies #Monoclonal #Pathology #diagnostics